Status:
COMPLETED
Magnesium Administration After Cardioplegic Arrest With Del Nido Cardioplegia
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Del Nido Cardioplegia
Eligibility:
All Genders
Brief Summary
The cardioplegia solution of choice in many pediatric cardiac congenital programs is the del Nido solution. While many cardioplegia solutions provide diastolic arrest, del Nido provides a longer perio...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients undergoing cardiac surgery requiring CPB and cardioplegic arrest with del Nido cardioplegia solution.
- Patients planned to receive post cross-clamp dose of 25 mg/kg magnesium sulfate.
Exclusion
Key Trial Info
Start Date :
January 24 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 15 2024
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT05298618
Start Date
January 24 2022
End Date
February 15 2024
Last Update
May 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital
Cincinnati, Ohio, United States, 45229